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ABSTRACT 
Meliponids are native bees of the Americas, characterized by having no sting (ANSA). Some live in the Yunga forests of northern 
Argentina, a place rich in a diversity of this type of bees of which at least thirty-three species may be found. Propolis is a resinous 
substance that bees collect from plants exudates. Chemical composition and functional properties vary according to the flora of the 
place where the hives are. They have been valued by humans for their biological properties for centuries. This study is aimed at 
investigating the antinociceptive, antioxidant and anti-biofilm activities of propolis from the stingless bees Tetragonisca fiebrigi 
Schwarz and Scaptotrigona jujuyensis Schrottky found in Estación Experimental Agropecuaria Famaillá of INTA, Tucumán, 
Argentina. Analgesic activity of the extracts was estimated against acetic acid induced writhing, tail immersion method and formalin 
test. Antioxidant capacity was evaluated using DPPH free radical scavenging and β-carotene bleaching assays. Propolis anti biofilm 
activity was tested on Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATTC 6538P bacteria. Phytochemical 
constituents were obtained using standard chemical methods. The propolis alcoholic extracts of the studied species possess 
antinociceptive activity at both central and peripheral levels as demonstrated by the three algesia tests used. Both propolis extracts 
were effective antioxidants in DPPH and β-carotene linoleic acid model systems. S. jujuyensis propolis tested at all doses against S. 
aureus and P. aeruginosa presented a selective biofilm inhibition unrelated to bacterial growth inhibition, thus achieving a reduction 
in pathogenicity. The chemical studies revealed the presence of sterols, triterpenes, catechins, coumarins, flavonoids, phenols, 
tannins and anthocyanidins. Chemical composition observed in the T.fiebrigi and S. jujuyensis propolis, suggest that those 
responsible for the activity would be chemical compounds of a non-phenolic nature. Our data indicate that geopropolis is a natural 
source of bioactive substances with promising beneficial properties for human health. Isolation and identification of compounds 
responsible for the pharmacological activities displayed by propolis has started.  
Keywords: Geopropolis; Scaptotrigona jujuyensis; Tetragonisca fiebrigi; Antinociceptive activity; Antioxidants; antimicrobial 
activity.  
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1. INTRODUCTION 
In recent decades, several researches have shown that 
analgesics represent one of the most studied therapeutic 
classes in the world. This fact is understandable due to 
the high consumption of these drugs worldwide, 
although they may have some adverse effects and low 
therapeutic efﬁcacy. Thus, the effort to develop new 
drugs has been the focus in the screenings of extracts 
from natural sources, which historically have led to the 
discovery of many clinically important drugs in the 
current therapy 
1,2
. Natural products from bees have been 
extensively employed since ancient times because of 
their broad pharmacological activity 
3,4
. 
Propolis has been widely utilized as a medicine and 
dietary supplement for its broad biological, 
antimicrobial, anti-inﬂammatory, immunomodulatory, 
and antioxidant activities 
5-7
. Additionally, a large 
number of studies have indicated that the reactive 
oxygen scavenging and antimicrobial activity may be 
attributed to the various natural phenolic components 
and ﬂavonoids with antioxidant effects and reducing 
activity present in propolis 
8,9
. 
Previous phytochemical studies demonstrated that  Apis 
mellifera propolis predominantly contains complex 
phenolic compounds which are responsible for its 
activities 
10
. However, chemical constituents and related 
bioactivities of each type of propolis depend on bee 
species, preference for resin and food plants, 
geographical regions, variation in plant resin 
compositions and accessible plant species 
11,12
. In 
general, the composition of Apis mellifera propolis 
primarily consists of resin (50%), wax (30%), essential 
and aromatics oils (10%), bee pollen (5%), and other 
substances (5%) Stingless bees are another bee species, a 
eusocial group which plays an important role in 
pollination
 
they produce a variety of propolis popularly 
known as geopropolis. It consists of a mixture of resin, 
wax and soil with distinctive physicochemical 
characteristics 
13
. In the Yunga forests of northern 
Argentina, a rich place in a diversity of this type of bees, 
at least thirty-three species may be found 
14
.
 
Although many studies about propolis have been 
published, most of them are from Apis mellifera. In 
contrast, very little is known about the chemical 
composition and biological activity of stingless bees 
propolis although it is frequently used in folk medicine.  
Other investigators have studied geopropolis collected 
by Melipona scutellaris a native Brazilian stingless bee1 
showed that Melipona scutellaris geopropolis has 
antinociceptive and anti-inﬂammatory properties 15,16. 
Ferreira Campos et al., (2015) reported phenolic 
compounds, aromatic acids, alcohols, terpenes and 
sugars in ethanol extracts of Tetragonisca fiebrigi 
propolis. These compounds have been identified in other 
studies of stingless bees propolis found in Brazil 
18,19
. T. 
fiebrigi ethanol extract showed antimicrobial activity 
against gram positive, gram negative and fungal 
bacteria, that cause respiratory pneumonia and common 
nosocomial infections in the urinary tract, and in post-
surgical, gastrointestinal and skin wounds 
20
.
 
Brodkiewicz et al., 2017 reported that oral 
administration of Scaptotrigona jujuyensis and T. 
fiebrigi propolis in rats showed antiinflamatory activity 
and  had no toxic effects. 
The aim of this work was to evaluate the 
antinociceptive, antioxidant and antibiofilm activities of 
ethanolic extracts of Tetragonisca fiebrigi Schwarz and 
Scaptotrigona jujuyensis Schrottky, (Apoidea) propolis 
to validate their traditional use. In addition, we assessed 
the phytochemical composition and measured the 
content of total phenolic compounds and flavonoids in 
the extracts in order to correlate them with the assayed 
activities. This work constitutes the first in vivo 
validation study of the antioxidant, antibiofilm and 
antinociceptive effect of stinglees bee propolis from 
Northwestern Argentina. 
2. MATERIALS AND METHODS 
2.1 Propolis sample 
In this work we used propolis of S. jujuyensis and T. 
fiebrigi. The hives are located in the Famaillá 
Agricultural Experiment Station of INTA, in the 
province of Tucumán, Argentina. The bees were 
identified and deposited in the Museo Argentino de 
Ciencias Naturales Benardino Rivadavia, Buenos Aires, 
Argentina. Samples of S. jujuyensis and T. fiebrigi 
propolis were collected and kept in a dry place and 
stored at 4 °C until its processing. Dry propolis was 
subjected to exhaustive maceration with 70% ethanol 
(1:7 w/v) in a shaker (300 rpm) at room temperature for 
72 h. The ethanol extract solution was then filtered and 
concentrated using a rotary evaporator to obtain the 
ethanol extracts of S. jujuyensis propolis (ESP) and T. 
fiebrigi propolis (ETP). 
2.2 Physical and chemical determinations  
Humidity: 4 g of powdered samples were heated in an 
oven at 105°C for 6 hours and cooled to room 
temperature in a desiccator until constant weight 
22
. 
Ash: 4 g of powdered samples were ashed at 550 ± 25 ° 
C for 4 hours, and cooled to room temperature in a 
desiccator until constant weight 
22
. 
Waxes: 2 g of powdered samples were treated with n-
hexane in a soxhlet for 6 hours. The extracts were 
concentrated to dryness in a water bath at 70°C, and then 
cooled to room temperature in a desiccator until constant 
weight 
23
.  
Resins:  soxhlet cartridge after extracting wax was 
extracted with ethanol 96% in a soxhlet until negative 
reaction to % ferric chloride (about 3 hours). The 
extracts were diluted to 100 ml with ethanol in a 
volumetric flask at 20°C. 50 ml were concentrated to 
dryness in a water bath at 100°C, then cooled in a 
desiccator until constant weight. The other 50 ml was 
kept in an amber flask to determine the content of total 
phenolic compounds and total flavonoids 
23
.
 
Mechanical mixtures: the residues, that stays in the 
soxhlet cartridge after extracting wax with hexane and 
resins with ethanol, is dryed in an oven at 105°C for 4 
hours, and cooled to room temperature in a desiccator 
until constant weight 
23
. 
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2.3 Phytochemical screening 
For the identification of the different groups of 
secondary metabolites present in the extracts of propolis, 
the techniques and procedure described by Miranda and 
Cuéllar, (2002) were used. 
2.4 Determination of total phenol content 
Total phenolic content was estimated by the Folin–
Ciocalteu method 
25
. Absorbance at 765 nm was 
measured after 30 min of incubation at room 
temperature. Gallic acid (0-10 mg/l) was used for the 
standard calibration curve. The results were expressed as 
mg gallic acid equivalent (GAE)/g dry weight, and 
calculated as mean value ± SD (n = 3). 
2.5 Total flavonoid content 
Total flavonoid content was determined by the 
colorimetric method of Christel et al., (2000). 
Absorbance was measured at 430 nm. Total flavonoid 
contents were calculated from a calibration curve using 
quercetin equilibrant (g QE /100 g dry matter) (Sigma 
Chem. Co., USA). 
2.6 Antioxidant activity  
2.6.1 DPPH scavenging activity 
The free radical scavenging activity of the extracts and 
positive controls (Quercetin and butylated 
hydroxytoluene) were investigated using 1,1 biphenyl -
2-picrylhydrazyl (DPPH) radical scavenging method 
27
. 
Absorbance at 517 nm was measured versus ethanol as a 
blank. All experiments were carried out in triplicate. The 
degradation of DPPH was evaluated against a control 
(0.25 ml of DPPH solution and 0.75 ml ethanol 96 %). 
Antioxidant activity was expressed as: 
Scavenging activity % = [(Abs control – Abs sample)/ 
Abs control] x 100  
2.6.2 β-carotene bleaching method 
The antioxidant activity of ethanolic extracts from 
propolis was evaluated using β–carotene–linoleate 
model system, as described by Sun and Ho, (2005). The 
absorbance at 470 nm was measured.  Quercetin or BHT 
was used as positive control and distilled water or 
solvent were the negative control. All samples were 
assayed in triplicate. The antioxidant activity (AA) was 
measured in terms of successful bleaching of β–carotene 
by using the equation: 
AA= [1- (A0 – At / A0
0
 – At 
0
)]  x 100 
Where A0 and A0
0
 were the absorbance values, before 
incubation for test sample and control respectively. At 
and At
0 
were the respective absorbance of the test sample 
and the control after incubation for 120 min. The results 
were expressed as % of the prevention of bleaching of 
β–carotene 29. 
2.7 Antimicrobial activity 
2.7.1 Bacterial growth 
Overnight cultures of P. aeruginosa ATCC 27853 and S. 
aureus ATTC 6538P were diluted to reach 2.5 × 10
6 
CFU/mL in Luria–Bertani (LB) and Mueller-Hinton 
(MH) media was used for P. aeruginosa and S. aureus, 
respectively. The diluted culture (190 μL) was placed in 
each of the 96 wells of a micro titer polystyrene plate. 
Solutions of extracts in DMSO–distilled water (1:1) 
were prepared separately and 10 μL of each was pipetted 
to the plastic micro titer plate wells individually (eight 
replicates) in order to reach final concentrations of 200, 
100, 50, and 5 μg/mL. Control wells (eight replicates) 
the ﬁnal concentration of DMSO is 2.5 %. Medium 
control was prepared using sterile LB and contained the 
diluted culture (190 μL) and 10 μL of a solution of 
DMSO–water (1:1) in which MH for to each 
microorganism. After 24 h incubation at 37 °C, bacterial 
growth was detected as turbidity (600 nm) using a micro 
titer plate reader (Power Wave XS2, Biotek, VT, USA).  
2.7.2 Biofilm formation assay  
For biofilm quantification, a micro method based on a 
protocol previously reported was employed 
30
.
 
Absorbance (540 nm) of ethanol solutions of crystal 
violet was determined using a micro titer plate reader 
(Power Wave XS2. Biotek, Vermont, USA). 
Ciprofloxacin, a known biofilm inhibitor, was 
incorporated in the same bioassay as a positive control at 
5 μg/mL. At this concentration, ciprofloxacin inhibited 
the biofilm formation but did not significantly modify 
the bacterial growth. 
2.8 Studies in vivo 
2.8.1 Animals 
Wistar male rats (weighing 220–240 g) were used for 
this study and were obtained from the Bioterio of the 
Facultad de Bioquímica, Química y Farmacia, Instituto 
de Biología (INSIBIO), Universidad Nacional de 
Tucumán. All animals were kept under normal 
laboratory conditions of humidity, temperature (25±1 
ºC) and light (12 h dark/light cycle), and allowed free 
access to food and water ad libitum. The studies were 
conducted in accordance with the internationally 
accepted principles for laboratory animal use and care 
(EEC Directive of 1986; 86/609/EEC). Prior to initiation 
of dosing, all rats were acclimated for 7 days and 
evaluated for weight gain and any gross signs of disease 
or injury. 
2.8.2 Antinociceptive assays 
2.8.2.1 Formalin-induced nociception  
The formalin test was carried similar to that described by 
Gorzalczany et al., (2011). Rats were injected with 20 μl 
of 2.5% formalin solution, into the sub-plantar region of 
the right hind paw 30 min after treatment with sterile 
water (control, p.o.), extracts of S. jujuyensis propolis 
(ESP) and T. fiebrigi propolis (ETP) (250, 500 and 1000 
mg/kg b.w.) and reference drugs ibuprofen syrup (100 
mg/kg b.w.) and morphine syrup (1 mg/kg b.w.). 
Licking time of the injected paw, was recorded as 
nociceptive response at 0–5 min (neurogenic phase) and 
15–30 min (inflammatory phase) after formalin injection 
2.8.2.2 Acetic acid-induced writhing method 
The acetic acid method was carried out as described by 
Reynoso et al. (2016). Thirty minutes before to acetic 
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acid injection, rats (n = 6 per group) were treated with 
extracts of S. jujuyensis propolis (ESP) and T. fiebrigi 
propolis (ETP) (250, 500 and 1000 mg/kg b.w., p.o.), 
sterile water (control, p.o.), morphine syrup (1 mg/kg 
b.w., p.o.) and ibuprofen syrup (100 mg/kg b.w., p.o.). 
Each group was administered 10 ml/kg b.w., i.p., of an 
aqueous solution of acetic acid (1.0%). After five 
minutes the rats were observed and the number of 
writhing was counted for 30 min.  
2.8.2.3 Tail immersion test 
To evaluate the central analgesic property the tail 
immersion test was performed 
33
. One to two cm of tail 
of the rats pretreated with extracts of S. jujuyensis 
propolis (ESP) and T. fiebrigi propolis (ETP) (250, 500 
and 1000 mg/kg b.w., p.o.), morphine syrup (1 mg/kg 
b.w., p.o.), ibuprofen syrup (100 mg/kg b.w., p.o.) and 
sterile water (p.o.) were immersed in warm water kept 
constant at 54 ± 0.5°C. The latency between tail 
immersion and deflection of tail was recorded. A latency 
period of 20 s was maintained to avoid tail tissue 
damage in mice. The latency period of the tail with draw 
al response was taken as the index of antinociception 
and was determined at 30, 60, 90, 120 and 150 min after 
the administration of the drug and extracts.   
2.9 Statistical analysis 
All experimental values are expressed as the mean ± the 
standard deviation of at least two independent 
experiments. Statistically signiﬁcant differences from 
the vehicle group were identiﬁed by Student’s test or 
ANOVA followed by Tukey test for paired data. The 
level of p ≤ 0.05 was used to determine statistical 
signiﬁcance.  
3. RESULTS 
3.1 Physical and chemical parameters 
The results of the characterization of geopropolis 
samples of T. fiebrigi and S. jujuyensis are shown in 
Table 1. Humidity values are in the range 1.58 - 2.57 
g/100g, wax in the range 76.43-67.30 g/100g, resins 
between 7.66 and 6.36, ash in the range 2.55–3.51 
g/100g, and mechanical mixtures between 14.23 and 
23.77 g/100g.  
3.2 Phytochemical screening 
The phytochemical screening of the main groups of 
chemical constituents of the propolis under study was 
qualitatively determined by simple reactions of 
coloration and precipitation. Table 2 shows the results of 
the phytochemical screening of ethanolic extracts of T. 
fiebrigi (ETP) and S. jujuyensis (ESP) propolis.
 
Table 1: Physical and chemical parameters 
Parameter Geopropolis 
 ETP ESP 
Humidity [g/100g] 1,58 ± 0,53  2,57 ± 0,43  
Ash [g/100g] 2,55 ± 0,70* 3,51 ± 0,23*  
Wax [g/100g] 76,43 ± 2,78*  67,30 ± 4,92*  
Resins [g/100g] 7,66 ± 0,98  6,36 ± 1,55  
Mechanical sludges [g/100g] 14,33 ± 1,73*  23,77 ± 3,74*  
Total phenolic substances [(1)g/100g] 0,12 ± 0,02  0,23 ± 0,05  
Total flavonoid substances  [(2)g/100g] 0,08 ± 0,04  0,08 ± 0,02  
1= gallic acid equivalent  
2= quercetin hydrate equivalent  
Values represent the mean ± SEM (n=6). * The asterisks denote the significance levels between the values in the same row, p < 
0.001 (one-way ANOVA, followed by Tukey’s test).  
 
Table 2: Phytochemical screening of the ethanol extracts T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis. 
Phytoconstituents Test ETP ESP 
Catechins Catechine + + 
Lactones Baljet + + 
saponins foam - - 
coumarins UV fluorescence + + 
flavonoids Shinoda + + 
sterols and Triterpenes Liebermann - Burchard + + 
phenols and tannins Ferric chloride + + 
quinones Bornträger - + 
cardenolics Kedde   
anthocyanidins Anthocyanidins + + 
alkaloids Dragendorf 
Mayer 
Wagner 
- - 
(+) Presence (-) Absence 
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The polyphenol and flavonoid contents of ethanolic 
extracts of T. fiebrigi (ETP) and S. jujuyensis (ESP) 
propolis are shown in Table 1. 
Total phenolic concentration in the extracts was 
expressed as g/GAE 100 g dry weight. The amount of 
total phenolic compounds in the ETP and ESP was 0.12 
and 0.23 g GAE/100 g respectively. 
Flavonoid concentration in the extracts was expressed as 
quercetin equivalents (QE)/100 g dry weight. The 
flavonoid content of the ethanol extract of T. fiebriyi 
(ETP) and S. jujuyensis (ESP) propolis was 0.08 ± 0.04 
and 0.08 ± 0.02 g QE/100 g dry weights respectively.  
3.3 DPPH radical scavenging activity 
The DPPH antioxidant assay is based on the ability of 
DPPH, a stable free radical, to decolorize in the 
presence of antioxidants. Figure 1A shows that the 
scavenging effects of samples on DPPH radical and 
were in the following order: QUER = BHT >ESP > 
ETP. The effective concentration 50 (IC 50), defined as 
the concentration at which the DPPH radicals were 
scavenged by 50 %, was 2.27 ± 0.12 mg/ml for the ETP 
and 1.72 ± 0.28 mg/ml for the ESP. Though the 
antioxidant potential of extracts was found to be low (P 
< 0.05) in comparison with BHT and quercetin (0.002 ± 
0.001 mg/ml and 0.080 ± 0.010 mg/ml respectively), the 
study revealed that ETP and ESP have a prominent 
antioxidant activity, 88.89 and 93.29 % at a 
concentration of 7 mg/ml respectively. 
3.4 Antioxidant activity determined by β-carotene 
bleaching method 
The antioxidant potential of the propolis extract was 
also evaluated by the β-carotene bleaching method. 
Figure 1B shows the decrease in absorbance of the β-
carotene emulsion in presence of 10 mg/ml of the 
extracts and 1 mg/ml of the reference antioxidants (BHT 
and Quercetin). The addition of 10 mg/ml of ETP and 
ESP extracts was effective in inhibiting the oxidation of 
linoleic acid and subsequent bleaching of β- carotene, in 
comparison with the control (p <0.05), which contained 
no antioxidant component. The percentages of activity 
were ETP (67.03 %), ESP (55.02 %), BHT (95.00 %) 
and Quercetin (93.00 %). The results indicated that the 
ETP and ESP extracts were effective antioxidants in a β-
carotene linoleic acid model system. 
 
A 
 
B 
 
Figure 1: Antioxidant activity of T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis. (A) DPPH radical scavenging activity. (B) 
Inhibition of lipid peroxidation. Quercetin and BHT were used as reference anti-oxidant. Values represent the mean ± S.E.M. (n=6). 
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3.5 Bacterial growth 
The effects of T. fiebrigi (ETP) and S. jujuyensis (ESP) 
propolis on (a) S. aureus ATTC 6538P and (b) P. 
aeruginosa ATCC 27853 are shown in Figure 2 in 
comparison with the control experiment. 
  
 
Figure 2: Effect of T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis at 200 µg/ml, 100 µg/ml, 50 µg/ml and 5 µg/ml 
on S. aureus ATTC 6538P growth (a) and P. aeruginosa ATCC 27853 growth (b). Bacterial growth was assessed by 
reading the absorbance at 560 nm. Vertical bars represent the standard deviation (n = 8). * The asterisks denote the 
significant difference compared with the control group, by means of ANOVA, followed by the Tukey test (p <0.05). 
Values in parentheses are percentage of inhibition. 
 
T. fiebrigi (ETP) propolis moderately inhibited S. 
aureus bacterial growth (67.39, 54.05, 45.02 and 
28.38%) at all the concentrations assayed (200, 100, 50, 
5 µg/ml). However, none of them inhibited P. 
aeruginosa bacterial growth.  
3.6 Bioﬁlm formation 
The absorbance of bioﬁlm (Figure 3), formed after 24 h 
incubation in the control media, stained with crystal 
violet, was 2.75.  
The decrease in biofilm production observed in S. 
aureus by T. fiebrigi (ETP) propolis may be due to the 
growth inhibition at all doses tested. However, S. aureus 
and P. aeruginosa biofilm production was inhibited by 
S. jujuyensis (ESP) propolis at all doses tested (Fig. 3). 
Since this inhibition was not related to that of bacterial 
growth (Figure 2), there was a reduction in 
pathogenicity.
 
Figure 3: Effect of T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis at 200 µg/ml, 100 µg/ml, 50 µg/ml and 5 µg/ml 
on S. aureus ATTC 6538P bioﬁlm production (a) and P. aeruginosa ATCC 27853 bioﬁlm production (b). Vertical bars 
represent the standard deviation (n = 8). * The asterisks denote the significant difference compared with the control 
group, by means of ANOVA, followed by the Tukey test (p <0.05). Values in parentheses are percentage of inhibition. 
T. fiebrigi (ETP) propolis only selectively inhibited the production of biofilm of P. aeruginosa (47.57 and 23.64%) at 
doses of 200 and 100 μg / ml respectively. 
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3.7 Antinociceptive study 
3.7.1 Formalin-induced pain 
Overall, the ethanol extracts of T. fiebrigi (ETP) and S. 
jujuyensis (ESP) propolis showed a significant (P < 
0.05) antinociceptive activity in both phases of the 
formalin-induced paw licking test (Figures 4A and 4B). 
Morphine was used as positive control (1 mg/kg b.w., 
p.o.) and the response time of the animals decreased 
signiﬁcantly when compared to the negative control in 
both phases, while the other positive control, ibuprofen 
(100 mg/kg b.w., p.o.), was effective only in the second 
phase (Figure 4B). 
In the first phase (Figure 4A), T. fiebrigi (ETP) and S. 
jujuyensis (ESP) propolis produced a significant 
(p<0.05) dose dependent inhibition of nociceptive 
reaction with a peak effect inhibitory effect (71.13 and 
75.28 %) at the highest dose (1000 mg/kg). This effect 
was statistically significant (p<0.05), but lower than that 
produced by morphine (86.54 % inhibition). In the 
second phase, the duration of the nociceptive reaction in 
the control group was 264.01±10.51 seconds. The 
ethanolic extract of T. fiebrigi (ETP) propolis 
significantly (p<0.05) inhibited the biting and licking 
response with a higher inhibitory effect (85.56 %) 
produced at the same dose. 
 
A 
 
B 
 
Figure 4: Effect of ethanolic extracts of T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis on the nociceptive response 
of the formalin test in first phase (A) and second phase (B). Control, ibuprofen (Ibu 100 mg/kg b.w.), morphine (Mor 1 
mg/kg b.w.), T.  fiebrigi propolis (250-500-1000 mg/kg b.w.) and S. jujuyensis propolis (250-500-1000 mg/kg b.w.). 
Values in parentheses are percentage of inhibition. * The asterisks denote the significance levels compared with the 
control group, p<0.05 (one-way ANOVA, followed by Tukey’s test). Values represent the mean ± SEM (n=6) 
 
3.7.2 Acetic acid-induced writhing method 
The oral antinociceptive doses of ethanolic extracts of T. 
fiebrigi (ETP) and S. jujuyensis (ESP) propolis (1000 
mg/kg b.w.) produced a significant inhibition of acetic 
acid i.p. induced abdominal constriction in rats (Figure 
5). 
The calculated inhibition for the ETP and ESP were 
77.97 % and 58.71 % respectively, significantly lower 
compared with dose morphine (89.99 %) and ibuprofen 
(94.49 %). 
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Figure 5: Effect of oral administration on acetic acid induced writing in rats. The intensity of nociception behavior was 
cuantified by counting the total number or writhes occurring 20 min following the stimulus injection. Rats were orally 
treated with control, ibuprofen (Ibu 100 mg/kg b.w.), morphine (Mor 1 mg/kg b.w.), ethanolic extracts of T. fiebrigi 
(ETP) and S. jujuyensis (ESP) propolis (EE 250-500-1000 mg/kg b.w.) Values in parentheses are percentage of 
inhibition. * The asterisks denote the significance levels compared with the control group, p<0.05 (one-way ANOVA, 
followed by Tukey’s test). Values represent the mean ± SEM (n=6) 
 
3.7.3 Tail immersion test 
A significant reduction of the painful sensation due to 
tail immersion in warm water was observed following 
oral administration of T. fiebrigi (ETP) and S. jujuyensis 
(ESP) propolis at doses of 500 and 1000 mg/kg b.w. 
(Table 1). The inhibitory effects of ETP and ESP 
became pronounced at 60 min, 65.36 % and 67.54% 
respectively, post dosing 1000 mg/kg b.w. The 
inhibitory effect of the ethanol extracts of both propolis 
was lower than that produced by morphine and 
statistically significant (p<0.05). Ibuprofen had no effect 
in this test. 
4. DISCUSSION 
The aim of this work was to evaluate the 
antinociceptive, antioxidant and antibiofilm activities of 
ethanolic extracts of T. fiebrigi and S. jujuyensis 
propolis to validate the traditional usage of this stingless 
bee’s propolis.  
Our results showed that the ethanol extract of T. fiebrigi 
(ETP) and S. jujuyensis (ESP) propolis had a 
significantly antinociceptive effect on three classical 
nociception models in rats: the formalin, the acetic acid 
induced writhing and the tail immersion tests, all of 
which are useful methods for screening prospective 
antinociceptive compounds.  
The intraperitoneal injection of acetic acid elicited 
writhing, a syndrome characterized by a wave of 
abdominal musculature contractions followed by 
extension of the hind limbs. This response is a sensitive 
procedure to establish peripherally acting analgesia that 
involves local peritoneal receptors on the surface of the 
cells lining the peritoneal cavity 
34
.
 
A significantly 
effective protection was observed in the groups of 
animals treated with ethanolic extracts of T. fiebrigi and 
S. jujuyensis propolis as compared with the standard 
drug (Ibuprofen) (Figure 5). Inhibition percentages were 
dose-dependent for the T. fiebrigi extract. The analgesic 
effect produced by the ethanolic extract of S. jujuyensis 
propolis was high in the three doses studied (250, 500 
and 1000 mg / kg). The agent that reduced writhing 
renders an analgesic effect preferably by inhibition of 
prostaglandin synthesis, a peripheral mechanism of pain 
inhibition 
35
.
 
However, the test of abdominal 
constrictions has a low specificity, since several 
compounds, such as antihistamines, neuroleptics and 
adrenergic blockers may also inhibit constrictions 
36
.
 
Hence, we used the formalin test, a chemical model of 
nociception, which provides a more specific response 
compared with the model of abdominal constrictions 
induced by acetic acid 
37
. 
A subcutaneous injection of formalin produces a distinct 
biphasic nociception. The first phase starts immediately 
after the formalin injection and continues for 5 min, 
after which nociception appears to diminish. The second 
phase starts as a return to high levels of nociception 
beginning 15~30 min after the formalin injection and 
continues for 60 min 
38
.
 
These phases have obvious and 
different properties that are very useful tools, not only 
for assessing the potency of analgesics, but also for 
elucidating the mechanisms of pain and analgesia. The 
action of analgesics is different in the first and second 
phases. Drugs such as narcotics (e.g. morphine, codeine, 
meperidine) which primarily act centrally, inhibit both 
phases equally, but peripherally acting drugs such as 
ibuprofen, aspirin, oxyphenbutazone, dexamethasone, 
and hydrocortisone only inhibit the second phase of 
formalin-induced nociception 
39,40
. The results of the 
present study showed that the ethanol extract of T. 
fiebrigi and S. jujuyensis propolis inhibited both the 
early and the late phases of formalin-induced pain 
(Figure 4), thus suggesting its central and peripheral 
antinociceptive actions. These results are similar to 
those obtained by Lima Cavendish (2015) in red 
propolis of Apis mellifera where the alcohol extract (30 
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mg / kg) decreased the response in the first and second 
phases, while acetylsalicylic acid, used as a positive 
control (300 mg / kg) inhibited only the second phase. 
Additionally, the extracts of T. fiebrigi and S. jujuyensis 
propolis produced a greater inhibition in the second 
phase. This effect was comparable to that produced by 
the standard drug (Morphine)(Figure 4B). 
Findings in the formalin test suggest that the ethanolic 
extracts of geopropolis act through a peripheral 
mechanism, as established in the mouse writhing test, 
demonstrating possible effectiveness in the treatment of 
chronic inflammatory pain by inhibition of associated 
inflammatory processes, basically associated to the 
release and/or action of inflammatory mediators. This 
assertion is supported by the report of Brodkiewicz et 
al., 2017 where ethanolic extracts of T. fiebrigi and S. 
jujuyensis propolis showed an anti-inflammatory 
activity via inhibition of histamine, serotonin, substance 
P and prostaglandin synthesis.  
In the tail immersion test, oral pre-treatment with the T. 
fiebrigi and S. jujuyensis propolis caused a profound and 
dose dependent analgesia in the treated animals although 
the analgesic effect was lower than that produced by 
morphine (Table 3). Animal response in this test is 
usually integrated at the lower level in the central 
nervous system, thus giving information about the pain 
threshold. Therefore, it is used to detect narcotic and 
non-narcotic analgesics. The ethanolic extracts of T. 
fiebrigi and S. jujuyensis propolis reached their 
maximum analgesic level 60 min after administration, 
similar to morphine. Ibuprofen did not show any activity 
in this test. 
 
Table 3: Effect of T. fiebrigi (ETP) and S. jujuyensis (ESP) propolis on pain with the tail immersion test 
    Interval following treatment (h) 
Treatment 
  
Dose 
(mg/Kg, p.o.) 
0.0 0.5 1.0 1.5 2.0 2.5 
Reaction time (seg) 
 
Control SW 2.05±0.15 2.25±0.10 2.40±0.10 2.40±0.11 2.05±0.05 2.05±0.04 
Ibuprofen 100 2.10±0.13 2.35±0.06 2.35±0.18 2.35±0.09 2.29±0.05 2.25±0.05 
Morphine 1 2.10±0.10 3.85±0.15 * 4.40±0.22 * 4.00±0.20 * 3.40±0.17 * 3.10±0.15 * 
S. jujuyensis 
propolis 
250 2.10± 0.09 2.74±0.20 * 3.06±0.33 * 2.81±0.08 * 3.36±1.57 * 3.12±0.43 * 
 500 2.15± 0.09 4.13±0.62 * 3.85±1.53 * 4.57±1.64 * 3.15±0.26 * 3.39±0.23 * 
 1000 2.10± 0.05 3.87±0.96 * 5.06±0.27 * 3.42±0.60 * 2.88±0.11 * 2.48±0.15 *  
T. fiebrigi propolis 250 2.20± 0.05 2.65±0.13 * 2.31±0.01  2.83±0.15 * 2.21±0.11  2.41±0.12 * 
 500 2.20± 0.09 3.29±0.45 * 4.68±1.70 * 3.52±1.14 * 2.89±1.14 * 3.27±0.57 * 
 1000 2.15± 0.15 4.05±0.08 * 4.35±3.18 * 3.18±0.88 * 3.35±0.04 * 2.84±0.06 * 
 
Values represent the mean ± SEM and are in seconds (n=6). * The asterisks denote the significance levels compared with the control 
group, p < 0.05 (one-way ANOVA, followed by Tukey’s test). SW (sterile water). 
 
Our results have shown that the alcoholic extracts of 
propolis of the species T. fibrigi and S. jujuyensis, have a 
significant antinociceptive effect in laboratory animals at 
high doses. Similar results were found for another 
meliponid species, Melipona scutellaria 
15
.
 
In recent years, various investigations have undertaken 
the study of propolis as an antioxidant of natural origin 
for the prevention and treatment of various diseases of 
oxidative origin 
42
.
 
The extracts were able to scavenge DPPH radicals, but 
especially that of T. fiebrigi propolis (Figure 1A), with 
IC50 of 2.27 ± 0.12 mg/ml. promoted a stronger DPPH 
radical scavenging activity than the others.  
In the -carotene bleaching assay, linoleic acid produces 
hydroperoxides as free radicals during incubation at 50 
1C. The presence of antioxidants in the extracts 
minimizes the oxidation of -carotene by 
hydroperoxides. There was a correlation between the 
degradation rate and the bleaching of b-carotene since 
the extract with the lowest -carotene degradation rate 
exhibited the highest antioxidant activity. The results 
indicated that the ETP and ESP extracts were effective 
antioxidants in a β-carotene linoleic acid model system 
at the doses tested (Figure 1B). However, all extracts 
assayed had a lower antioxidant activity than BHT and 
Quercetin, in agreement with the results from Ozsoy et 
al. (2008). 
Biofilm production of S. aureus and P. aeruginosa was 
inhibited by S. jujuyensis (ESP) propolis (Figure 3), but 
it was not related to the bacterial growth inhibition 
(Figure 2). The percentage of bioﬁlm inhibition by 
propolis extracts was higher than the percentage of 
growth inhibition by the same compounds. The relation 
between bioﬁlm production (measured at DO540 nm) 
and bacterial growth (measured at DO560 nm) was 
deﬁned as speciﬁc bioﬁlm produced, i.e., bioﬁlm that 
each bacterium forms 
43
. The speciﬁc bioﬁlm production 
for the control media was 0.53 and 0,60 for P. 
aeruginosa and S. aureus. If DO relation of the 
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treatments is lower than that of the control, it indicates 
that the specific production of biofilm was inhibited. 
Under the conditions studied, the S. jujuyensis propolis 
extract tended to reduce bioﬁlm speciﬁc production of S. 
aureus and P. aeruginosa at all doses tested. The 
speciﬁc bioﬁlm production was on average 0.33 in S. 
aureus and 0.46 in P. aeruginosa. T. fiebrigi ethanolic 
extracts reduced the specific production of biofilm in P. 
aeruginosa only at the highest doses tested (specific 
production of biofilm 0,43 and 0,40 at 200 and 100 μg / 
ml respectively). 
Chemical constituents and related bioactivities of each 
type of propolis depend on bee species, preference for 
resin and food plants, geographical regions, variation in 
plant resin compositions and accessible plant species 
11
.
 
Phenolic compounds are reported by many authors as 
being responsible for the biological activity observed in 
Apis mellifera propolis 
5,44
, but there are very few data 
on the propolis of ANSA. 
The chemical studies revealed the presence of sterols, 
triterpenes, catechins, coumarins, flavonoids, phenols, 
tannins and anthocyanidins (Table 2). The propolis 
evaluated had a low content of phenolic compounds, 
flavonoids and resins and a high content of waxes 
(Table1). Similar results were obtained by Franchin et 
al., 2013. The differences in chemical composition 
observed in the ANSA propolis analyzed in this paper 
suggest that those responsible for the observed activity 
would be chemical compounds of a non-phenolic nature. 
5. CONCLUSIONS 
Although meliponid hive products have many 
advantages, meliponiculture has not become popular in 
Argentina yet, as it has in Mexico and Brazil. The 
studies published on these species are very scarce and 
have not been carried out at the same chemical and 
pharmacological level. These results signify that these 
geopropolis alcoholic extracts are an important source of 
natural analgesics, antioxidants and antipathogenics 
which might play a vital role as novel potential 
therapeutic agents for the alleviation of infection and 
inflammatory pain. Chemical compounds of a non-
phenolic nature would be responsible for the observed 
activity. Isolation of pharmacologically active molecules 
through directed bioassay is now in progress. 
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